Megostat 40 mg/ml oralna suspenzija
| Name | Megostat 40 mg/ml oralna suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-142933667 |
| Active Substance | megestrolacetat |
| Composition | 1 ml suspenzije sadrži 40 mg mikroniziranog megestrolacetata |
| Pharmaceutical Form | oralna suspenzija |
| Manufacturer | Bausch Health Poland sp. z o.o., Rzeszow, Poljska Bausch Health Poland sp. z o.o., Mysłowice, Poljska |
| Marketing Authorisation Holder | Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 10.03.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/166 |
| Registration Number | 381-12-01/70-20-31 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02AB01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
